| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |